SaiyanMed
Finnrick has tested 30 samples from SaiyanMed across 5 products.
saiyanmed.com/Finnrick verified this link on 24 Jun 2026
Take Action
Request Full Data Access to the Finnrick database of peptide tests.
Products
| Tests | ||||||||
|---|---|---|---|---|---|---|---|---|
| Product | Rating | Count | Avg | Min | Max | Oldest | Most Recent | |
| Melanotan II | 2 | 3 Aug 2026 | 3 Aug 2026 | |||||
| Tirzepatide | 5 | 5 Nov 2025 | 9 Aug 2026 | |||||
| Retatrutide | 14 | 4 Nov 2025 | 21 Aug 2026 | |||||
| Tesamorelin | 4 | 13 Mar 2026 | 5 Aug 2026 | |||||
| BPC-157 | 2 | 3 Aug 2026 | 3 Aug 2026 | |||||
Some samples were submitted by SaiyanMed as part of the Launch with Finnrick vendor support program. Samples are otherwise either acquired by Finnrick directly, or submitted by the public.
Customer Reviews
These indicators of customer satisfaction are based on reports submitted by the public through the Finnrick testing program, and are not verified.
Based on 24 overall satisfaction reports
People who submitted test requests to Finnrick gave SaiyanMed an average satisfaction rating of 4.3 out of 5 across 24 reports associated with samples received and tested by Finnrick.
Most recent SaiyanMed tests
Samples are tested in commercial labs
tests
products
Scores
First
Last
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Product | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 21 Aug 2026 | Retatrutide | View | 30mg | 30.5mg | +1.7% | 99.90% | n/a | SYM-RETA B2606 | No label / Silver crimp / Violet cap | Lab G | Public | |
| 13 Aug 2026 | Retatrutide | View | 10mg | 9.35mg | -6.5% | 99.90% | n/a | April 10, 2026 | No label / Silver crimp / Black cap | Lab E | Public | |
| 13 Aug 2026 | Retatrutide | View | 10mg | 9.07mg | -9.3% | 99.90% | low | SM-RT10-0620 | No label / Silver crimp / Black cap | Lab E | Public | |
| 9 Aug 2026 | Tirzepatide | View | 30mg | 33.3mg | +11.0% | 99.80% | n/a | (no batch ID) | No label / Silver crimp / Gray cap | Lab G | Public | |
| 6 Aug 2026 | Retatrutide | View | 20mg | 20.7mg | +3.5% | 99.90% | n/a | RT20 | No label / Silver crimp / Blue cap | Lab G | Public | |
| 5 Aug 2026 | Retatrutide | View | 30mg | 25.5mg | -15.0% | 99.90% | low | SYM-RETA-B2606 | Orange, White label / Silver crimp / Violet cap | Lab E | Vendor | |
| 5 Aug 2026 | Retatrutide | View | 30mg | 24mg | -20.0% | 99.90% | low | SYM-RETA-B2606 | Orange, White label / Silver crimp / Violet cap | Lab E | Vendor | |
Launch with Finnrick
Some of the samples listed on this page were submitted by their vendor, as part of the Launch with Finnrick vendor support program.
The program is designed to help vendors get listed on the Finnrick web site while protecting the integrity of our rating system.
The vendor submitted four samples per product, two of which were tested by Finnrick for identity, purity and quantity according to our usual process. The vials were anonymized before being sent to the testing lab.
About SaiyanMed Test Results From Finnrick
SaiyanMed is a peptide vendor with multiple products tracked in the independent testing dataset collected by Finnrick. This page compiles recent, batch-level test results across 5 products and 30 tests, including scores, test dates, batch IDs, and lab details. This enables you to compare quality over time, not just marketing claims.
Each tested sample receives a 0–10 score, with 10 being the best possible value. It is the total of three components: purity (0–4 points), quantity accuracy vs. the label or batch claim (0–4 points), and batch information quality (0–2 points).
When several test results are available for a product and vendor pair, you’ll also find a Finnrick Rating (A–E, where A is best and E is worst, X if an insufficient number of tests is available, or F in rare cases of documented and widespread fraud) and customer satisfaction reports with sub-scores that provide additional context. Use the table above to review purity, quantity accuracy, consistency between batches, and any notable outliers surfaced in Finnrick testing data.
SaiyanMed Testing Activity & Score Summary
In the past 30 days, Finnrick has published 20 new test results for SaiyanMed, and 23 in the past three months. The overall dataset includes 30 tested samples with an average score of 8.0/10 across all products.
Across 27 identity-tested samples, 100% were confirmed to contain the expected peptide (identity pass rate). Among those that passed, median purity was 99.9%. Approximately 96% of passing samples tested at or above 98% purity.
Here is a closer look at the most frequently tested products (top 3):
- Retatrutide (14 tests, 100% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 5.0 to 10.0 (average 8.3/10), suggesting significant batch-to-batch differences.
- Tesamorelin (4 tests, 100% identity pass, median purity 99.9%) — Test scores are highly variable, ranging from 5.0 to 10.0 (average 7.8/10), suggesting significant batch-to-batch differences.
- Tirzepatide (5 tests, 100% identity pass, median purity 99.8%) — Test scores are highly variable, ranging from 6.0 to 9.7 (average 8.1/10), suggesting significant batch-to-batch differences.